FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY (EIN 841363353) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Principal Officer

LINDA MILLER MPA

Phone

4029207003

Tax Period

2024-01-01 to 2024-12-31

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY, founded in 1996, is a community nonprofit in the Medical Research sector that reported $7.2M in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. Expenses of $6.3M left a modest 12% surplus.

Mission

FACT IS A NON-PROFIT CORPORATION FOUNDED TO IMPROVE THE QUALITY OF CELLULAR THERAPY THROUGH PEER-DEVELOPED STANDARDS, EDUCATION AND ACCREDITATION FOR THE BENEFIT OF PATIENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $500,000

Program Service Revenue $6,666,377

Investment Income $12,129

Other Revenue $0

TOTAL REVENUE $7,178,506

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $3,566,942

Other Expenses $6,341,397

TOTAL EXPENSES $6,341,397

Year-over-Year Comparison

	2024	2023	Change
Revenue	$7,178,506	$5,475,747	+0.3%
Expenses	$6,341,397	$4,962,781	+0.3%
Net Income	$837,109	$512,966	+0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

487

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$823,691

Total Directors

$823,691

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ABBA ZUBAIR MD	BOARD MEMBER	0.25	Director	$0	$0	$0
ALAN BALCH PHD	BOARD MEMBER	0.25	Director	$0	$0	$0
C FRED LEMAISTRE MD	PAST PRESIDENT	1.25	Officer Director	$0	$0	$0
CARLOS BACHIER MD	SECRETARY	1.25	Officer Director	$0	$0	$0
CARLOS RAMOS MD	TREASURER	1.25	Officer Director	$0	$0	$0
CATHERINE BOLLARD MD	PRESIDENT	1.25	Officer Director	$0	$0	$0
DANIEL COURIEL MD	BOARD MEMBER	0.25	Director	$0	$0	$0
DAVID SCHMAHL	CHIEF EXEC OFFICER	40.00	Officer Director	$238,095	$0	$238,095
ELIZABETH SHPALL MD	VICE PRESIDENT	1.25	Officer Director	$0	$0	$0
ENEIDA NEMECEK MD	BOARD MEMBER	0.25	Director	$0	$0	$0
HUY PHAM MD	BOARD MEMBER	0.25	Director	$0	$0	$0
LINDA MILLER MPA	CHIEF OPER OFFICER	50.00	Officer Director	$238,038	$0	$238,038
MARY GRABLE MCLEOD	BOARD MEMBER	0.25	Director	$0	$0	$0
NADIM MAHMUD MD	BOARD MEMBER	0.25	Director	$0	$0	$0
NAVNEET MAJHAIL MD	BOARD MEMBER	0.25	Director	$0	$0	$0
NICOLE PROKOPISHYN	STANDARDS CHAIR	1.25	Director	$0	$0	$0
PATRICK HANLEY PHD	BOARD MEMBER	0.25	Director	$0	$0	$0
PHILLIP JOHNSON	BOARD MEMBER	0.25	Director	$0	$0	$0
PHYLLIS WARKENTIN MD	CHIEF MED OFFICER	50.00	Officer Director	$347,558	$0	$347,558
SERGIO GIRALT MD	BOARD MEMBER	0.25	Director	$0	$0	$0
WANXING CUI MD PHD	BOARD MEMBER	0.25	Director	$0	$0	$0
ALISA FORSYTHE	DIRECTOR OF TECHNOLOGY SER	40.00	Highest	$130,780	$0	$130,780
JOSEPH SCHWARTZ	SENIOR MEDICAL OFFICER	40.00	Highest	$263,000	$0	$263,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$7,178,506	$6,341,397	$3,752,677	$837,109
2023	$5,475,747	$4,962,781	$2,915,569	$512,966
2022	$4,719,051	$4,363,156	$2,402,603	$355,895
2021	$3,571,480	$3,205,464	$2,046,708	$366,016
2020	$3,340,959	$2,679,864	$1,680,692	$661,095
2019	$3,319,475	$2,974,036	$1,019,597	$345,439
2018	$2,736,616	$2,748,016	$674,158	$-11,400

FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY